Arch Oncology

Profound Bio

This clinical-stage biotechnology company develops antibody-drug conjugates and targeted therapies for patients with solid tumors and hematological malignancies.

CellmAbs

This biotech company develops monoclonal antibodies and adoptive cell therapies to treat oncology patients with solid tumours.

Aktis Oncology

This biotechnology company develops alpha-emitting radiopharmaceuticals to treat patients with solid tumor cancers.

Bioarchitech

This company develops viral and RNA immunotherapies designed to help the immune systems of cancer patients target and destroy tumours.

Alphina Therapeutics

This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.

Arxx Therapeutics

This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.

ALX Oncology

This clinical-stage biopharmaceutical company develops novel therapies to treat cancer patients by expanding the possibilities of immuno-oncology and antibody-drug conjugates.

Abologix

The company develops monoclonal antibody therapeutics to treat drug-resistant lymphomas and solid tumours for cancer patients.